Citigroup »

Plus Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $15k 93k 0.16
2025-03-31 $139 146 0.95
2023-09-30 $775 579 1.34

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Plus Therapeutics

Vanguard Capital Management
Vanguard Group
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Virtu Financial
State Street Corporation
Northern Trust
Millennium Management
XTX Topco
Two Sigma Securities
Citigroup
UBS Group
Mercer Global Advisors
Vanguard Global Advisers

View all funds holding Plus Therapeutics